Stock Research for AEZS

AEZS

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

AEZS Stock Chart & Research Data

The AEZS chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the AEZS chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


AEZS Due diligence Resources & Stock Charts

The AEZS stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View AEZS Detailed Price Forecast - CNN Money CNN View AEZS Detailed Summary - Google Finance
Yahoo View AEZS Detailed Summary - Yahoo! Finance Zacks View AEZS Stock Research & Analysis - Zacks.com

Stock Analysis

TradeIdeas View AEZS Trends & Analysis - Trade-Ideas Barrons View AEZS Major Holders - Barrons
NASDAQ View AEZS Call Transcripts - NASDAQ Seeking View AEZS Breaking News & Analysis - Seeking Alpha
Spotlight View AEZS Annual Report - CompanySpotlight.com OTC Report View AEZS OTC Short Report - OTCShortReport.com
TradeKing View AEZS Fundamentals - TradeKing Charts View AEZS SEC Filings - Bar Chart
WSJ View Historical Prices for AEZS - The WSJ Morningstar View Performance/Total Return for AEZS - Morningstar
MarketWatch View the Analyst Estimates for AEZS - MarketWatch CNBC View the Earnings History for AEZS - CNBC
StockMarketWatch View the AEZS Earnings - StockMarketWatch MacroAxis View AEZS Buy or Sell Recommendations - MacroAxis
Bullish View the AEZS Bullish Patterns - American Bulls Short Pains View AEZS Short Pain Metrics - ShortPainBot.com

Social Media Mentions

StockTwits View AEZS Stock Mentions - StockTwits PennyStocks View AEZS Stock Mentions - PennyStockTweets
Twitter View AEZS Stock Mentions - Twitter Invest Hub View AEZS Investment Forum News - Investor Hub
Yahoo View AEZS Stock Mentions - Yahoo! Message Board Seeking Alpha View AEZS Stock Mentions - Seeking Alpha


Financial & Transaction Holdings

SECform4 View Insider Transactions for AEZS - SECform4.com Insider Cow View Insider Transactions for AEZS - Insider Cow
CNBC View AEZS Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for AEZS - OTC Markets
Yahoo View Insider Transactions for AEZS - Yahoo! Finance NASDAQ View Institutional Holdings for AEZS - NASDAQ


Stock Charts

FinViz View AEZS Stock Insight & Charts - FinViz.com StockCharts View AEZS Investment Charts - StockCharts.com
BarChart View AEZS Stock Overview & Charts - BarChart Trading View View AEZS User Generated Charts - Trading View




Latest Financial News for AEZS


Aeterna Zentaris Provides Corporate Update
Posted on Thursday June 06, 2019

Aeterna Zentaris Inc. (AEZS) (AEZS) today announced that it is reducing the size of its German workforce and operations to more closely reflect the Company's ongoing commercial activities in Frankfurt. The Company is also providing an update on the previously disclosed securities class action lawsuit pending in the U.S. District Court for the District of New Jersey, brought on behalf of shareholders of the Company. The lawsuit alleges violations of the Securities Exchange Act of 1934 in connection with allegedly false and misleading statements made by the defendants between August 30, 2011 and November 6, 2014 regarding the safety and efficacy of Macrilen™ (macimorelin) and the prospects for the approval of the Company's New Drug Application for the product by the FDA.


Aeterna Zentaris Announces Results of Annual and Special Shareholders’ Meeting
Posted on Wednesday May 08, 2019

CHARLESTON, S.C., May 08, 2019 -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) announced today at its annual and special shareholders’ meeting held on May 8, 2019, that the.


Aeterna Zentaris (AEZS) Reports Q1 Loss, Misses Revenue Estimates
Posted on Tuesday May 07, 2019

Aeterna Zentaris (AEZS) delivered earnings and revenue surprises of -450.00% and -99.12%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?


Aeterna Zentaris: 1Q Earnings Snapshot
Posted on Tuesday May 07, 2019

The Summerville, South Carolina-based company said it had a loss of 30 cents per share. Losses, adjusted for non-recurring costs and research and development costs, came to 14 cents per share. The drug ...


Stock Market & Investing Books

Enter a stock symbol to view the stock details.